Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Colorado

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Haematologica|May 14, 2026
Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI studyPilar Lloret-Madrid, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2025
Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI StudyPau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, et al.
Blood|June 8, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA studyJosé Vicente Gil, Claudia Sargas, Rosa Ayala, et al.
American Journal of Hematology|April 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA StudyGaspar Aspas Requena, Rebeca Rodríguez-Veiga, Cristina Gil, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Haematologica|May 14, 2026
Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI studyPilar Lloret-Madrid, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2025
Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI StudyPau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, et al.
Blood|June 8, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA studyJosé Vicente Gil, Claudia Sargas, Rosa Ayala, et al.
American Journal of Hematology|April 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA StudyGaspar Aspas Requena, Rebeca Rodríguez-Veiga, Cristina Gil, et al.
Pageof 5